
Current Price | $2.63 | Mkt Cap | $125.0M |
---|---|---|---|
Open | $2.67 | P/E Ratio | -47.39 |
Prev. Close | $2.63 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $2.60 - $2.74 | Volume | 105,881 |
52-Wk Range | $2.08 - $5.16 | Avg. Daily Vol. | 156,068 |
Current Price | $2.63 | Mkt Cap | $125.0M |
---|---|---|---|
Open | $2.67 | P/E Ratio | -47.39 |
Prev. Close | $2.63 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $2.60 - $2.74 | Volume | 105,881 |
52-Wk Range | $2.08 - $5.16 | Avg. Daily Vol. | 156,068 |
The best Bull and Bear pitches based on recency and number of recommendations.
I'm not going to bet against Auerbach. The successful lobbying for CHMP re-review is the latest example of his being able overcome naysayers. Given Nerlynx potential to win greater use and his past M&A exit with Cougar/JNJ, I'm thinking this one… More
Puma has 0 Revenue and a $1.57 Billion market cap. Crazy overvalued and bearish trend.
Read the most recent pitches from players about PBYI.
Recs
I'm not going to bet against Auerbach. The successful lobbying for CHMP re-review is the latest example of his being able overcome naysayers. Given Nerlynx potential to win greater use and his past M&A exit with Cougar/JNJ, I'm thinking this one makes sense to buy here.
Recs
Prior success with leadership. Successfully bringing approved drugs to market. Will either continue to grow with successful trials or be acquired.
Recs
Puma has 0 Revenue and a $1.57 Billion market cap. Crazy overvalued and bearish trend.
Find the members with the highest scoring picks in PBYI.
IBDContrarian (65.98) Score: +266.82
The Score Leader is the player with the highest score across all their picks in PBYI.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
IBDContrarian | 65.98 | 4/8/2013 |
![]() |
5Y | $30.95 | -91.50% | +175.31% | +266.82 | 1 Comment | |
kevrose31 | 79.18 | 1/10/2014 |
![]() |
1Y | $110.14 | -97.61% | +132.39% | +230.00 | 0 Comment | |
SimonSaysSell | 98.86 | 4/16/2014 |
![]() |
NS | $73.01 | -96.40% | +130.48% | +226.88 | 0 Comment | |
sobek1 | 77.90 | 8/6/2014 |
![]() |
1Y | $230.97 | -98.86% | +123.68% | +222.54 | 0 Comment | |
YourDailyBear | 42.75 | 1/14/2016 |
![]() |
1Y | $49.32 | -94.67% | +122.51% | +217.17 | 1 Comment | |
jayningpan | 63.67 | 8/18/2014 |
![]() |
5Y | $262.01 | -99.00% | +116.77% | +215.77 | 0 Comment | |
bumpyjr | 21.62 | 7/23/2014 |
![]() |
5Y | $230.35 | -98.86% | +115.16% | +214.02 | 0 Comment | |
jackbot | 98.28 | 7/24/2014 |
![]() |
5Y | $214.06 | -98.77% | +115.15% | +213.92 | 0 Comment | |
theMetz | 23.91 | 7/24/2014 |
![]() |
1Y | $226.00 | -98.84% | +115.00% | +213.83 | 0 Comment | |
newbie07 | 75.45 | 7/24/2014 |
![]() |
5Y | $226.00 | -98.84% | +115.00% | +213.83 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.